Pallas Capital Advisors »

Blueprint Medicines shares owned by Pallas Capital Advisors

Quarter-by-quarter ownership of Blueprint Medicines (BPMC) shares owned by Pallas Capital Advisors from 13F filings

Historical chart of Pallas Capital Advisors investment in Blueprint Medicines

Tip: Access up to 7 years of quarterly data

All positions including Blueprint Medicines held by Pallas Capital Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Blueprint Medicines by Pallas Capital Advisors

Quarter filed Position value Share count Share price at filing
2024-03-31 $496k 5.2k 94.86
2023-12-31 $479k 5.2k 92.24
2023-09-30 $365k 6.7k 54.34
2023-06-30 $388k 6.7k 57.89

More positions owned by Pallas Capital Advisors

Bruker Corporation (BRKR)
Global Partners Com Units (GLP)
Microsoft Corporation (MSFT)
Amazon (AMZN)
J P Morgan Exchange Traded F Active Bond Etf (JBND)
Apple (AAPL)
Fidelity Merrimack Str Tr Total Bd Etf (FBND)
Alphabet Cap Stk Cl A (GOOGL)
Principal Exchange Traded Spectrum Pfd (PREF)
Vanguard Scottsdale Fds Mtg-bkd Secs Etf (VMBS)
Indexiq Active Etf Tr Iq Mackay Intrme (MMIT)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
JPMorgan Chase & Co. (JPM)
Ishares Tr 7-10 Yr Trsy Bd (IEF)
Broadcom (AVGO)

View all positions for Pallas Capital Advisors

Top funds holding Blueprint Medicines

Vanguard Group
T. Rowe Price Associates
Wellington Management Company
William Blair Investment Management
Jpmorgan Chase & Co
Lord, Abbett & Co
Alliancebernstein
Brown Advisory Holdings Incorporated
Avidity Partners Management
Norges Bank Investment Management
Goldman Sachs Group
Charles Schwab Investment Management
Emerald Advisers
Point72 Asset Management
Bank of America Corporation

View all funds holding Blueprint Medicines